Efficacy of novel oral formulations of α/β arteether against multidrug-resistant malaria in mice

Chemotherapy

Volumn 56, Issue 3, 2010, Pages 178-183

  Tripathi, Renu ^a   Khanna, Madhu ^a   Dwivedi, Anil Kumar ^a  

^a CENTRAL DRUG RESEARCH INSTITUTE   (India)

Author keywords

Arteether; Antimalarials; Blood schizontocide; Malaria; Multidrug resistance; Oral formulation; Plasmodium yoelii nigeriensis

Indexed keywords

ARTEETHER; MACROGOL 400; MACROGOL 6000;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; DRUG FORMULATION; FEMALE; MALARIA; MALE; MULTIDRUG RESISTANCE; NONHUMAN; PARASITEMIA; PLASMODIUM YOELII; PRIORITY JOURNAL; SURVIVAL RATE;

ADMINISTRATION, ORAL; ANIMALS; ANTIMALARIALS; ARTEMISININS; DRUG RESISTANCE, MULTIPLE; FEMALE; ISOMERISM; MALARIA; MALE; MICE; PLASMODIUM YOELII;

EID: 77952510139     PISSN: 00093157     EISSN: None     Source Type: Journal    
DOI: 10.1159/000315066     Document Type: Article

References (41)

1. Boudreau EF, Webster HK, Pavanand K, Tosingha L: Type II mefloquine resistance in Thailand: Lancet: 1982; 337: 1140-1143.
2. Eyles DE, Hoo CC Warren M, Sandosham AA: Plasmodium falciparum resistant to chloroquine in Cambodia. Am J Trop Med Hyg 1963; 12: 840-843.
3. Nosten F, ter Kuile FO, Chongsuphajaisiddhi T, Luxemberger C, Webster HK, Edstein M, Phaipun L, Thew KL, White NJ: Mefloquineresistant falciparum malaria on the Thai- Burmese border. Lancet 1991; 337: 1140-1143.
4. Timmermanns PM, Hessu Jones ME: Pyrimethamine/ sulfadoxine resistant falciparum malaria in East Africa. Lancet 1982; 22: 1181.
5. Dua VK, Dev V, Phookaw S, Gupta NC, Sharma VP, Subbarao SK: Multi-drug resistant Plasmodium falciparum malaria in Assam, India: timing of recurrence and antimalarial drug concentrations in whole blood. Am J Trop Med Hyg 2003; 69: 555-557.
6. World Health Organization: WHO Guidelines for the Treatment of Malaria. Geneva, WHO, 2006, Technical Document WHO/ HTM/MAL/2006.1108.
7. Sowunmi A, Balogun T, Gbotosho GO, Happi CT, Adedeji AA, Bolaji OM, Fehintola FA, Folarin OA: Activities of artemether-lumefantrine and amodiaquine-sulfalene-pyrimethamine against sexual-stage parasites in falciparum malaria in children. Chemotherapy 2008; 54: 201-208.
8. Brewer TG, Grate SJ, Peggins JO, Weina PJ, Petras JM, Levine BS, Heiffer MH, Schuster BG: Fatal neurotoxicity of arteether and artemether. Am J Trop Med Hyg 1994; 51: 251-259.
9. Petras JM, Kyle DE, Gettayacamin M, Young GD, Bauman RA, Webster HK, Corcoraw JD, Peggins JO, Vane MA, Brewer TG: Arteether: risks of two-week administration in Macaca mulatta . Am J Trop Med Hyg 1997; 57: 390-396.
10. Li QG, Mog SR, Si YZ, Kyle DE, Gettayacamin M, Milhous WK: Neurotoxicity and efficacy of arteether related to its exposure times and exposure levels in rodents. Am J Trop Med Hyg 2002; 66: 516-525.
11. Gordi T, Lepist EI: Artemisinin derivatives: toxic for laboratory animals, safe for humans? Toxicol Lett 2004; 147: 99-107.
12. Kissinger E, Hien TT, Hung NT, Nam ND, Tuyen NL, Dinh BV, Mann C, Phu NH, Loe PP, Simpson JA, White NJ, Farrar JJ: Clinical and neurophysiological study of the effects of multiple doses of artemisinin on brainstem function in Vietnamese patients. Am J Trop Med Hyg 2000; 63: 48-55.
13. Meshnick SR, Taylor TE, Kamchonwongpaisan S: Artemisinin and the antimalarial endoperoxides: from herbal remedy to targeted chemotherapy. Microbiol Rev 1996; 60: 301-315.
14. Asthana OP, Srivastava JS, Das Gupta P: Post-marketing surveillance of arteether in malaria. J Assoc Physicians India 2002; 50: 539-545.
15. Dutta GP, Jain DC, Bhakuni RS, Saxena S, Dhawan S, Singh Khanuja SP, Kumar S, Tripathi R, Umesh A, Kamal N, Dwivedi AK, Singh S: Synergistic antimalarial formulation. US Patent 2001, 6,326,023.
16. Bajpai R, Dutta GP, Vishawakarma R: A blood schizontocidal activity of new antimalarial drug, arteether (alpha/beta) against Plasmodium knowlesi in rhesus monkeys. Trans R Soc Trop Med Hyg 1989; 83: 484.
17. Dutta GP, Bajpai R, Vishawakarma RA: Antimalarial efficacy of arteether against multiple drug resistant strain of Plasmodium yoelii nigeriensis. Pharmacol Res 1989; 21: 415-419.
18. Tripathi R, Vishwakarma RA, Dutta GP: Plasmodium fragile: efficacy of arteether (alpha/ beta) against cerebral malaria model. Exp Parasitol 1997; 87: 290-292.
19. Mishra SK, Asthana OP, Mohanty S, Patnaik JK, Das BS, Srivastava JS, Satpathy SK, Dash S, Rath PK, Varghese K: Effectiveness of alpha, beta-arteether in acute falciparum malaria. Trans R Soc Trop Med Hyg 1995; 89: 299-301.
20. Mohapatra PK, Khan AM, Prakash A, Mahanta J, Srivastava VK: Effect of arteether alpha/beta on uncomplicated falciparum malaria cases in Upper Assam. Indian J Med Res 1996; 104: 284-287.
21. Asthana OP, Srivastava JS, Pandey TK, Viswanath K, Gupta S, Valecha N, Srivastava VK, Mohapatra PK, Mahanta J, Mohapatra KM, Nayak NC, Dev V, Singh N, Sukla MM, Balsara AB, Das B, Satpathy SK, Mohany S, Misra SK, Kamboj VP, Sharma VP: Clinical efficacy of arteether in complicated and uncomplicated P. falciparum malaria. Indian J Pharmacol 1997; 29: 34.
22. Dietz R, Fagundes SMS, Brito EF, Milaw EP, Feitosa TF, Suassuna FAB, Fonschiffrey G, Ksionski G, Dember J: Treatment of kalaazar in Brazil with Amphocil (amphotericin B cholesterol dispersion) for 5 days. Trans R Soc Trop Med Hyg 1995; 89: 309-311.
23. Peters W, Davies EF, Robinson BL: The chemotherapy of rodent malaria, XXIII. Casual prophylaxis. II. Practical experience with Plasmodium yoelii nigeriensis in drug screening. Ann Trop Med Parasitol 1975; 69: 311-328.
24. Tripathi R, Jefford CW, Dutta GP: Blood schizontocidal activity of selected 1,2,4-trioxanes (Fenozans) against the multidrugresistant strain of Plasmodium yoelii nigeriensis (MDR) in vivo. Parasitology 2006; 133: 1-9.
25. Nontprasert A, Pukrittayakamee P, Nosten BM, Vanijanonta S, White NJ: Studies of the neurotoxicity of oral artemisinin derivatives in mice. Am J Trop Med Hyg 2000; 62: 409-412.
26. Alkadi HO: Antimalarial drug toxicity: a review. Chemotherapy 2007; 53: 385-391.
27. Price RN, van Vugt M, Phaipun L, Luxemburger C, Simpson J, McGready M, ter Kuile FO, Kham A, Chongsuphajaisiddhi T, White NJ, Nosten F: Adverse effects in patients with acute falciparum malaria treated with artemisinin derivatives. Am J Trop Med Hyg 1999; 60: 547-555.
28. van Vugt M, Looareesuwan S, Wilairatana P, McGready R, Villegas L, Gathmann I, Mull R, Brockman A, White NJ, Nosten F: Artemether- lumefantrine for the treatment of multidrug-resistant falciparum malaria: Trans R Soc Trop Med Hyg 2000; 94: 545-548.
29. White NJ: Qinghaousu (artemisinin): the price of success. Science 2008; 320: 330-334.
30. Pareek A, Nandy A, Kochar D, Patel KH, Mishra SK, Mathur PC: Efficacy and safety of beta arteether and alpha/beta arteether for treatment of acute Plasmodium falciparum malaria. Am J Trop Med Hyg 2006; 75: 139-142.
31. Davidson DE Jr: Role of arteether in the treatment of malaria and plans for further development. Trans R Soc Trop Med Hyg 1994; 88(suppl 1):51-52.
32. Lugt CB: Dutch registration for artemotil injection. TDR News 2000; 63: 13.
33. Thuma PE, Bhat GJ, Mabeza GF, Osborne C, Biemba G, Shakankale GM, Peeters PA, Oosterhuis B, Lugt CB, Gordeuk VR: A randomized controlled trial of artemotil (arteether) in Zambian children with cerebral malaria. Am J Trop Med Hyg 2000; 62: 524-529.
34. Li Q, Lugt CB, Looareesuwan S, Krudsood S, Wilairatana P, Vannaphan S, Chalearmrult K, Milhous WK: Pharmakokinetic investigation on the therapeutic potential of artemotil (beta-arteether) in Thai patients with severe Plasmodium falciparum malaria. Am J Trop Med Hyg 2004; 71: 723-731.
35. Dutta GP, Tripathi R: New antimalarial drug development in India: arteether - a blood schizontocide. Proc Indian Nat Sci Acad 2001;B69: 861-870.
36. Sabarinath S, Asthana OP, Puri SK, Srivastava K, Madhusudanan KP, Gupta RC: Clinical pharmacokinetics of the diastereomers of arteether in healthy volunteers. Clin Pharmacokinet 2005; 44: 1191-1203.
37. Sabarinath S, Madhusudanan KP, Gupta RC: Pharmacokinetics of the diastereomers of arteether, a potent antimalarial drug, in rats. Biopharm Drug Dispos 2005; 26:211-223.
38. Singh C, Verma VP, Naikade NK, Singh AS, Hassam M, Puri SK: Novel bis- and tris- 1,2,4-trioxanes: synthesis and antimalarial activity against multidrug-resistant Plasmodium yoelii in Swiss mice. J Med Chem 2008; 51: 7581-7592.
39. Chiou WL, Riegelman S: Preparation and dissolution characteristics of several fastrelease solid dispersions of griseofulvin. J Pharm Sci 1969; 58: 1505-1510.
40. Chiou WL, Riegelman S: Oral absorption of griseofulvin in dogs: increased absorption via solid dispersion in polyethylene glycol 6000. J Pharm Sci 1970; 59: 937-942.
41. Chiou WL, Riegelman S: Absorption characteristics of solid dispersed and micronized griseofulvin in man. J Pharm Sci 1971; 60: 1376-1380.